<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – E4_DM2_STRICT – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BA02)</td>
					<td>Metformin</td>
					<td>43387</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 88.47447949591142%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E11)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>29905</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 60.982075490935785%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E11)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus</td>
					<td>27386</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 55.84534758049715%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>20106</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 41.00002039193295%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>17820</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 36.33842451926018%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>16960</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 34.58471828544628%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH01)</td>
					<td>Sitagliptin</td>
					<td>12548</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 25.587797467321927%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB12)</td>
					<td>Glimepiride</td>
					<td>9188</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 18.73610799567691%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK03)</td>
					<td>Empagliflozin</td>
					<td>6122</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 12.483941352800832%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>5263</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 10.732274312282062%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E119)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4893</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.977772793083057%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD07)</td>
					<td>Metformin and sitagliptin</td>
					<td>4865</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.920675380819349%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>4778</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.743265564142826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E119)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>4764</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.71471685801097%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH05)</td>
					<td>Linagliptin</td>
					<td>4507</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.190644181161932%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB01)</td>
					<td>Glibenclamide</td>
					<td>4308</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.784844715430577%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>3956</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.067048675543955%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK01)</td>
					<td>Dapagliflozin</td>
					<td>3217</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.5600848304410775%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX01)</td>
					<td>Guar gum</td>
					<td>3135</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.392870980240217%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2706</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.518057056628398%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E11)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus</td>
					<td>2509</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.116335977487306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>2478</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.0531209853382%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG03)</td>
					<td>Pioglitazone</td>
					<td>2471</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.038846632272273%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>2393</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.879789555251942%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>2371</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.834927302759028%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2257</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.60245926711393%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ02)</td>
					<td>Liraglutide</td>
					<td>2188</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.461754929749791%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>2099</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 4.280266726483004%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH02)</td>
					<td>Vildagliptin</td>
					<td>1958</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.9927404718693285%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>1896</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.8663104875711167%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1832</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.7358021166826405%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E11)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus</td>
					<td>1721</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.509451660922939%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E119)</td>
					<td>Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>1713</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.493138114561879%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1614</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.291257978343767%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>1579</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.2198862130141315%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD03)</td>
					<td>Metformin and rosiglitazone</td>
					<td>1411</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.8773017394318807%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BG02)</td>
					<td>Rosiglitazone</td>
					<td>1323</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.6978527294602253%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>1225</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.4980117865372455%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX07)</td>
					<td>Liraglutide</td>
					<td>1202</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.4511103407492%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma</td>
					<td>1198</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.44295356756867%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB07)</td>
					<td>Glipizide</td>
					<td>1186</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.4184832480270804%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX02)</td>
					<td>Repaglinide</td>
					<td>992</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.0228797487713863%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX04)</td>
					<td>Exenatide</td>
					<td>964</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.9657823365076776%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>886</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.8067252594873469%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>854</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.7414710740431085%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>824</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6802952751891351%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E11)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus</td>
					<td>822</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6762168885988704%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>807</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6456289891718836%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX09)</td>
					<td>Dapagliflozin</td>
					<td>804</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6395114092864864%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>794</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6191194763351617%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>785</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.60076673667897%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ01)</td>
					<td>Exenatide</td>
					<td>759</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5477477110055262%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ06)</td>
					<td>Name not found</td>
					<td>757</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.5436693244152613%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD08)</td>
					<td>Metformin and vildagliptin</td>
					<td>719</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.4661799792002284%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>590</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.2031240441281428%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E118)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>583</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1888496910622157%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>579</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.180692917881686%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E118)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>575</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1725361447011562%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>529</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0787332531250637%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ05)</td>
					<td>Dulaglutide</td>
					<td>518</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0563021268786068%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>513</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0461061604029445%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>509</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0379493872224148%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD20)</td>
					<td>Metformin and empagliflozin</td>
					<td>498</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.0155182609759579%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E119)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>471</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9604600420073819%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E117)</td>
					<td>Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>464</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.9461856889414548%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>421</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8585003772507597%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD15)</td>
					<td>Metformin and dapagliflozin</td>
					<td>405</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8258732845286405%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD05)</td>
					<td>Metformin and pioglitazone</td>
					<td>404</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.8238340912335081%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E118)</td>
					<td>Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>378</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7708150655600644%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E11)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus</td>
					<td>337</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6872081404596342%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E11)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus</td>
					<td>314</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.640306694671588%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E1100)</td>
					<td>Non-insulin dependent diabetes diabetic hypoglycaemic coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>261</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.5322294500295683%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD11)</td>
					<td>Metformin and linagliptin</td>
					<td>235</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4792104243561247%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E119)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>232</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4730928444707274%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E112)</td>
					<td>Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>192</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.39152511266542955%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>171</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.3487020534676482%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>160</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.32627092722119133%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH03)</td>
					<td>Saxagliptin</td>
					<td>160</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.32627092722119133%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>140</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.28548706131854235%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>137</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.27936948143314505%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>117</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.23858561553049612%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>111</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.22635045575970145%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>106</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.21615448928403924%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX12)</td>
					<td>Empagliflozin</td>
					<td>104</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.21207610269377433%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E119)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>84</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.17129223679112543%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>82</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.16721385020086055%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma</td>
					<td>78</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.15905707702033076%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E112)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>73</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14886111054466855%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E112)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>71</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14478272395440364%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>70</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14274353065927117%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2500A)</td>
					<td>Diabetes mellitus without mention of complication</td>
					<td>69</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14070433736413876%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E117)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>65</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13254756418360897%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E118)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>64</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.13050837088847653%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E117)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>60</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.12235159770794674%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E115)</td>
					<td>Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1162340178225494%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(E1101)</td>
					<td>Non-insulin dependent diabetes diabetic coma with hyperglycaemia</td>
					<td>57</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1162340178225494%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E114)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>56</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11419482452741696%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E114)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>55</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1121556312322845%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E116)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>53</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10807724464201962%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>51</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10399885805175471%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10195966475662228%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E116)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10195966475662228%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E112)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>50</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10195966475662228%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD19)</td>
					<td>Linagliptin and empagliflozin</td>
					<td>48</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09788127816635739%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E117)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>47</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09584208487122495%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E119)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>46</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0938028915760925%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E116)</td>
					<td>Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>44</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08972450498582761%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BH04)</td>
					<td>Alogliptin</td>
					<td>44</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08972450498582761%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX03)</td>
					<td>Nateglinide</td>
					<td>41</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08360692510043027%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD9(E11)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>37</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07545015191990048%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2503A)</td>
					<td>Diabetes mellitus, Diabetes with other coma</td>
					<td>35</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07137176532963559%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD10)</td>
					<td>Metformin and saxagliptin</td>
					<td>35</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07137176532963559%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>34</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06933257203450315%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E113)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>33</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.0672933787393707%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06525418544423826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>32</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06525418544423826%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E110)</td>
					<td>Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06321499214910582%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E110)</td>
					<td>Diabetes, insulin-treated, Name not found</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06321499214910582%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E113)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06321499214910582%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E113)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>31</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06321499214910582%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK02)</td>
					<td>Kanagliflozin</td>
					<td>30</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.06117579885397337%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E114)</td>
					<td>Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>28</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05709741226370848%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E110)</td>
					<td>Diabetes, non-insulin-treated, Name not found</td>
					<td>27</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05505821896857604%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E117)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05301902567344358%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>26</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05301902567344358%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2507A)</td>
					<td>Diabetes mellitus, Diabetes with peripheral circulatory disorders</td>
					<td>25</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.05097983237831114%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E114)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>24</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.048940639083178694%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(2504A)</td>
					<td>Diabetes mellitus, Diabetes with renal manifestations</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04690144578804625%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>23</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.04690144578804625%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>22</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.044862252492913805%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(E1109)</td>
					<td>Non-insulin-dependent diabetes mellitus - With coma. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.040783865902648916%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E112)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.040783865902648916%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E118)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.040783865902648916%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E111)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03874467260751647%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E118)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03874467260751647%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E111)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>16</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.03262709272211913%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD09)</td>
					<td>Pioglitazone and alogliptin</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.030587899426986684%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E111)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ketoacidosis</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02854870613185424%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(E110)</td>
					<td>Name not found</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02854870613185424%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD13)</td>
					<td>Metformin and alogliptin</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02854870613185424%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02854870613185424%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E112)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With renal complications</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02854870613185424%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(E113)</td>
					<td>Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>13</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.02650951283672179%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BJ03)</td>
					<td>Lixisenatide</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.024470319541589347%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BK04)</td>
					<td>Name not found</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.024470319541589347%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E114)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>12</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.024470319541589347%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BD21)</td>
					<td>Saxagliptin and dapagliflozin</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.022431126246456903%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(103)_ICD10(E115)</td>
					<td>Diabetes, insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>11</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.022431126246456903%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(346)_ICD10(E116)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.020391932951324458%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E113)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01835273965619201%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E114)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With neurological complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01835273965619201%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(215)_ICD10(E115)</td>
					<td>Diabetes, non-insulin-treated, Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01835273965619201%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(310)_ICD10(E119)</td>
					<td>Orlistat, sibutramine and other major and expensive medicines used to treat obesity, Non-insulin-dependent diabetes mellitus - Without complications</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.016313546361059566%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BB02)</td>
					<td>Chlorpropamide</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01427435306592712%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug purchase">PURCH</abbr></td>
					<td>PURCH_ATC(A10BX10)</td>
					<td>Lixisenatid</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01427435306592712%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(358)_ICD10(E117)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With multiple complications</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.01427435306592712%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(160)_ICD10(E116)</td>
					<td>exenatide, Non-insulin-dependent diabetes mellitus - With other specified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012235159770794674%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(162)_ICD10(E113)</td>
					<td>liraglutide, Non-insulin-dependent diabetes mellitus - With ophthalmic complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012235159770794674%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(177)_ICD10(E118)</td>
					<td>Insulin glargine 300 U / ml, Non-insulin-dependent diabetes mellitus - With unspecified complications</td>
					<td>6</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.012235159770794674%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2505A)</td>
					<td>Diabetes mellitus, Diabetes with ophthalmic manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010195966475662229%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2506A)</td>
					<td>Diabetes mellitus, Diabetes with neurological manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010195966475662229%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD9(2508A)</td>
					<td>Diabetes mellitus, Diabetes with other specified manifestations</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010195966475662229%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(285)_ICD10(E115)</td>
					<td>Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults), Non-insulin-dependent diabetes mellitus - With peripheral circulatory complications</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.010195966475662229%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
